Latest News

Deckers Outdoor recently reported first-quarter 2026 results, showing sales of US$1,019.53 million and net income of US$129.97 million, while also updating full-year 2027 guidance to higher expected revenue, slightly better than 21.5% operating margin, and diluted EPS of US$7.35–US$7.50 supported by ongoing share repurchases. The company’s decision to tie its raised earnings outlook to repurchasing shares worth roughly 80% of projected fiscal 2027 free cash flow underlines how capital...

The market has treated ElringKlinger like a balance sheet headache in recovery mode, yet the latest quarter tells a more nuanced story. The stock closed at €5.13 on 5 August, only slightly higher over the past month and still down over the last quarter. Against that backdrop, Q2 earnings showed solid revenue of €478.9m and net income of €11.2m, with management highlighting stronger operating free cash flow and a reinforced cash position. For investors, the real headline is that ElringKlinger...

Services led growth across major European economies is starting to firm up, while input costs ease and inflation pressures cool. That mix often pushes investors toward companies where cash flows matter more than headlines. When sentiment shifts, undervalued stocks based on cash flows can attract attention quickly. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that stand out on discounted cash flow value and quality. The three stocks covered...

FRP Holdings stock slipped 2.4% to US$21.93 after its Q2 report, yet the real story sits in a different place than the share chart. The headline this quarter is a squeeze on profitability. Trailing net profit margin has compressed to 0.3% compared with 16.5% a year earlier, and reported earnings over the past five years have retreated at an average rate of 45.8% a year. Investors are reacting to that margin picture more than to the solid real estate platform or cash on hand. The question now...

Marqeta stock just handed investors a 7% one day drop, yet the earnings story leans far more toward a profitability grind than a collapse. Coming into the print, the stock had been roughly flat over three months, with only a small gain over 30 days. Then the market met a payments platform that printed about US$176m in Q2 net revenue and roughly US$8m in net income, its second straight profitable quarter. The real headline is margin power. Adjusted earnings before interest, tax, depreciation...

Penske Automotive Group recently reported past second-quarter 2026 results, with sales rising to US$8,297.2 million while net income eased to US$260.4 million and basic earnings per share from continuing operations slipped to US$3.96. Over the same period, the company also continued its long-running repurchase program, buying 94,711 shares for US$16.1 million and bringing total buybacks under the 2010 authorization to 31.05 million shares, or 38.85% of its shares at launch. We’ll now examine...

Blackstone (BX) is in focus after reporting second quarter results on July 23, 2026, that showed higher revenue and net income compared with a year earlier, alongside a larger quarterly dividend for shareholders. See our latest analysis for Blackstone. At a share price of $136.03, Blackstone has seen a 7 day share price return of 5.12% and a 30 day share price return of 10.22%. Year to date the share price return is down 14.34%, while the 3 year total shareholder return of 49.50% points to a...

Datalogic went into this earnings print with a stock that had gone nowhere over the past week and was slightly down over the past three months, while a rich P/E multiple sat on top of that flat performance. The Q2 numbers now give investors a clearer focal point. Revenue reached €128.16m and basic earnings per share came in at €0.044, which marks a return to profit after the loss in Q1. For a company known for bar code scanners and industrial data capture, this quarter is focused on whether...

Louisiana-Pacific stock barely budged after earnings, up just 0.7% to US$77.36, yet the quarter itself was anything but quiet. The company posted Q2 2026 revenue of US$664m and basic earnings per share of US$0.37, with investors weighing those construction cycle exposed numbers against a rich trailing P/E of about 100x. The real story for you is the squeeze between modest profits and a high multiple, especially with trailing net profit margin running at 2.2% and a recent one off loss still...

Zeta Global Holdings went into this earnings print as a high growth marketing and AI platform stock with a loyal bull camp and a lot to prove on profitability. The market liked what it saw. The share price jumped 11.6% to US$27.07 after the release, extending a strong three month run. The headline this quarter is profit. Zeta Global Holdings shifted from a loss in Q1 to GAAP net income of US$8.2 million, with basic earnings per share of US$0.03, on revenue of US$442.8 million. That move into...

Moderna (NasdaqGS:MRNA) has started the first Phase 1 clinical trial of an mRNA vaccine targeting the Bundibugyo strain of the Ebola virus. The trial follows authorization from Health Canada and is conducted in partnership with the Coalition for Epidemic Preparedness Innovations, or CEPI. Moderna and CEPI have pledged to support access to the Bundibugyo ebolavirus vaccine for low and middle income countries if it is approved. For investors watching how Moderna's mRNA platform extends beyond...

The market had already pushed Fresenius SE KGaA up over the past quarter, with the stock closing at €46.65 on 5 August after a solid 90 day run. Today investors had to decide whether that optimism fits the new reality. The headline is clear. Fresenius delivered a health care earnings story built on profit quality, not hype, with core earnings per share for Q2 of €0.68 and group EBIT margin at 12.3%. The emotional pivot is this margin story. Traders focused on short term headlines risk missing...

Healthpeak Properties stock barely budged, up less than 1% to around US$21.79, even though the earnings story was all about stronger cash generation. For a real estate investment trust, funds from operations is what matters, and Healthpeak reported adjusted funds from operations of US$0.46 per share in the quarter with total revenue of US$771.6m. The market reaction looks muted compared with that core cash figure and a raised full year adjusted funds from operations guidance range. Investors...

Banc of California, Inc. reported second-quarter 2026 results showing net interest income of US$250.5 million but a net loss of US$241.35 million, a reversal from net income a year earlier, alongside basic and diluted losses per share of US$1.61 from continuing operations. The quarter also saw net charge-offs surge to US$160,281,000 from US$44,222,000 a year ago, highlighting a sharp deterioration in credit costs even as management emphasized balance sheet repositioning efforts. We’ll now...

What the latest Lamb Weston guidance tells you Lamb Weston Holdings (LW) has just paired mixed fourth quarter and full year earnings with cautious fiscal 2027 guidance, flagging expected net sales growth of 0.0% to 1.0% alongside softer profitability measures. For you as an investor, that combination of modest sales expectations, declining net income and earnings per share, and commentary on waning demand presents questions about how the stock reflects slower organic growth and international...

American Electric Power Company, Inc. has already reported its second-quarter 2026 results, with sales rising to US$5,311 million and revenue to US$5,445 million, while net income declined to US$713 million and diluted EPS from continuing operations eased to US$1.30. For the first half of 2026, the company paired higher revenue of US$11,465 million with lower net income of US$1,587 million and issued full-year GAAP EPS guidance of US$6.16 to US$6.46, highlighting a shift toward top-line...

Hudbay Minerals (TSX:HBM) is back in focus after reporting second quarter 2026 results, reaffirming its full year production guidance and detailing leadership changes tied to its Copper World growth plans. See our latest analysis for Hudbay Minerals. That backdrop of solid second quarter earnings, confirmed 2026 production guidance and new leadership appointments appears to be feeding into strong momentum in Hudbay Minerals’ stock, with a 1 year total shareholder return of 187.60% and a year...

Niagen Bioscience stock just absorbed a sharp reality check, closing at US$2.96, which is a 14.7% slide from the prior session. That kind of move grabs attention, yet the Q2 print itself was more muted than the chart suggests. Revenue landed at US$29.8m and net income was about US$1m, keeping the company in the black but at a much slimmer level than earlier quarters. For investors with a longer lens, the headline is not the single quarter. It is how this thinner profitability sits against...

Higher-for-longer interest rate talk is back, with Minneapolis Fed President Neel Kashkari and other policymakers floating fresh hikes while inflation readings such as CPI at 3.5% and PCE at 3.7% keep pressure on cash. That puts short-duration fixed income and cash equivalent stocks in the spotlight as investors reassess where to park money. This article profiles 3 stocks that screen well against this rate shock story. The three stocks highlighted below are just a starting sample, with the...

In early August 2026, Gartner reported second-quarter results showing revenue of US$1,675.94 million, net income of US$275.5 million, and diluted EPS of US$4.14 from continuing operations, while updating 2026 guidance to target at least US$6.38 billion in FX-neutral revenue. Gartner also intensified capital returns by repurchasing 3,600,000 shares for US$547 million in the quarter, bringing cumulative buybacks under its long-running program to 32,840,858 shares for US$7.39 billion, which...

The market just put Gibraltar Industries on a pedestal. The stock jumped 14.2% to US$54.86 the first trading day after earnings, after already strong gains over the past quarter. That kind of one day repricing only happens when investors decide the story has changed. The headline this time is clear. Q2 revenue reached about US$509.5m with the first full quarter of OmniMax in the fold and adjusted earnings per share landed solidly in profitable territory after a weak Q1. The real question for...

Hamilton Lane (HLNE) stock drew fresh attention after the company reported earnings and revenue above market estimates, and it also announced an 11% higher full year dividend target of US$2.40 per share. See our latest analysis for Hamilton Lane. Despite the strong quarter and higher dividend guidance, Hamilton Lane’s recent news has played out against a mixed price backdrop, with the share price up 25.1% over the last month yet down 26.2% year to date and the 1 year total shareholder return...

Springer Nature KGaA stock closed at €18.90 on Wednesday, roughly flat over the past week and modestly higher over the past month. This suggests investors took a measured view of the fresh half year numbers. The headline is margin power. Adjusted operating profit reached €246m on €940m of revenue, lifting the adjusted operating margin into the mid 20s and reinforcing the publishing group’s profit profile. Short term traders may focus on the muted share reaction. Longer term holders will...

Sally Beauty Holdings reported past third-quarter 2026 results showing sales of US$935.49 million and higher year-on-year earnings, while also trimming its full-year Fiscal 2026 consolidated net sales guidance to a range of US$3.73 billion to US$3.73 billion. At the same time, the company is pushing COLORfest and COLORfest on Campus and broadening into skin and body care, highlighting a focus on younger consumers and higher-margin categories despite its more cautious sales outlook. We’ll now...